OTC · CYDX
CYduct Diagnostics, Inc.
$0.50$0.00 (0.0%)
CYduct Diagnostics, Inc.’s quoted price sits in the lower half of its reported 52-week range, 82.76% below the high.
Loading market information…
OTC · EDXC · USD
Stock price, earnings
Quote as of Oct 28, 2026, 08:00 PM UTC. Cached market data; not a live quote.
One-year closing-price history · USD. Historical prices are not a forecast.
Endexx Corporation’s quoted price sits in the lower half of its reported 52-week range, 99.75% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
BEHIND THE RESULTS
Upcoming dates and analyst estimates may change. Fiscal quarters follow Endexx Corporation’s reporting calendar.
THE COMPANY BEHIND THE TICKER
Endexx Corporation operates within the health and wellness industry, specializing in the development and commercialization of products based on cannabidiol (CBD). The company offers a comprehensive range of CBD-infused items, including creams, oils, capsules, extracts, topicals, beverages, chocolates, and specialized formulations for pets. Additionally, it provides health and beauty care solutions derived from hemp. These products are specifically designed to offer therapeutic alleviation of pain and inflammation for both human and animal consumers. Endexx distributes its offerings through its dedicated e-commerce platform, cbdunlimited.com, as well as via other online retailers and brick-and-mortar stores. The entity was previously identified as CBD Unlimited, Inc., until it formally adopted the name Endexx Corporation in May 2020. Its corporate headquarters are located in Cave Creek, Arizona.
Latest available per-share figures in USD. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 04:20 AM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
$0.50$0.00 (0.0%)
CYduct Diagnostics, Inc.’s quoted price sits in the lower half of its reported 52-week range, 82.76% below the high.
$0.03-$0.00 (0.0%)
Bionoid Pharma, Inc.’s quoted price sits in the lower half of its reported 52-week range, 93.3% below the high.
$0.18$0.00 (0.0%)
Procyon Corporation’s quoted price sits in the lower half of its reported 52-week range, 35.71% below the high.
$0.00+$0.00 (+100.0%)
Herborium Group, Inc.’s quoted price sits in the upper half of its reported 52-week range, 0.0% below the high.
$0.00-$0.00 (-25.0%)
Medical Marijuana, Inc.’s quoted price sits in the lower half of its reported 52-week range, 62.5% below the high.
$0.00$0.00 (0.0%)
Opus Holdings, Inc.’s quoted price sits in the lower half of its reported 52-week range, 66.67% below the high.
$0.00$0.00 (0.0%)
Yooma Wellness Inc’s quoted price sits in the upper half of its reported 52-week range, 0.0% below the high.
$0.00$0.00 (0.0%)
BioTech Medics, Inc.’s quoted price sits in the lower half of its reported 52-week range, 97.65% below the high.
